Almac has launched a new offering for the provision of [14C]-labelled Antibody Drug Conjugates (ADCs). Radiolabelling of drugs remains is effective methodology to facilitate absorption, distribution, metabolism and excretion (ADME) studies, and [14C] labelling of ADCs is becoming a critical part of their development.   Almac has integrated biology, chemistry, peptide and purification science, analytical and quality disciplines within their isotope laboratories. According to the company, the abil...